SlideShare ist ein Scribd-Unternehmen logo
1 von 11
MALARIA
• Submitted to- Mr. Appras willas Submitted by: Rahul
Pal
INTRODUCTION
• Malaria is a mosquito born-disease caused by plasmodium, which is transmitted
by the bite of infected female anopheles mosquito.
• The term malaria originated from Italian word: mal’
aria – “bad air”.
- Malaria remains the world’s most devastating human parasitic infection.
Malaria affects over 40% of the world’s population. WHO, estimates
that there are 350-500 million cases of malaria worldwide.
- In India 2 million cases & 100 deaths annually.
HISTORY
• Malaria is the associated disease have been noted 4000 years ago.
• Malaria may have contributed to the decline of the Roman Empire, and was so pervasive
in Rome that it was known as the “Roman fever”.
• Scientific studies on malaria made their first significant advance in 1880, when Charles
Louis Alphonse Laveran – a French army doctor working In the military hospital of
Constantine in Algeria – observed parasites inside the red blood cells of infected people
for the first time. For this & later discoveries, he was awarded the 1907 Noble prize for
physiology or medicines.
• The first effective treatment for malaria came from the bark of cinchona tree, which
contains quinine.
SYMPTOMS OF MALARIA
• Physical findings may include:
• Elevated temperature.
• Weakness.
• Enlarged spleen.
• Increased respiration rate.
OTHER SYMPTOMS:
• Dry cough.
• Muscle or back pain or both.
• Loss of consciousness.
• Infection of brain or spinal cord.
• Skin may be chills & sweating.
• Nausea & vomiting.
PATHOGENESIS
• Incubation period:10-14 days in P.vivax, P.falciparum & P. oval but it 28-30 days in
P.malariae.
• The typical clinical features consists of febrile paroxysm, anemias & splenomegaly.
STAGES OF DISEASE
• Cold stage= -feeling of intense cold.
• -Vigorous shivering, rigor.
• - Lasts 15-60 min.
• Hot stage- = Intense heat.
• =Dry burning skin.
• = Lasts 2-6 hours.
• Sweating stage= -Profuce sweting.
• - Declining temperature.
• -Lasts 2-4 hours.
DIAGNOSIS
• Laboratory: thin, thick smears, antigen capture & PCR etc.
• Clinical : platelets.
• Other tastes: CBC
• Lukopenia, throbocytobenia & increase ESR.
• Chest x ray- helpful if respiratory symptoms are present.
• CT scan- to evaluate evidence of cerebral edema or hemorrhage.
TREATMENT
Drug:
• 01). Cloroquine.
• 02). Primaquine.
• 03). quinine.
• 04). Artemisinin.
Active Ingredient
• 4-aminoquinolone.
• 8-aminoquinolone.
• Quinine.
• Sesquiterpene lactone.
Malaria Presentation Onwards Rahul Pals.pptx
Malaria Presentation Onwards Rahul Pals.pptx

Weitere ähnliche Inhalte

Ähnlich wie Malaria Presentation Onwards Rahul Pals.pptx

Ähnlich wie Malaria Presentation Onwards Rahul Pals.pptx (20)

Typhoid fever or enteric fever
Typhoid fever or enteric feverTyphoid fever or enteric fever
Typhoid fever or enteric fever
 
MALARIA AND AIDS.pptx
MALARIA AND AIDS.pptxMALARIA AND AIDS.pptx
MALARIA AND AIDS.pptx
 
Malaria
Malaria Malaria
Malaria
 
seminar on Malaria
seminar on Malaria seminar on Malaria
seminar on Malaria
 
Malaria shyam
Malaria shyamMalaria shyam
Malaria shyam
 
Arbovirus
ArbovirusArbovirus
Arbovirus
 
Bovine Epemeral Fever Disease: Introduction
Bovine Epemeral Fever Disease: IntroductionBovine Epemeral Fever Disease: Introduction
Bovine Epemeral Fever Disease: Introduction
 
Malaria
MalariaMalaria
Malaria
 
Anthrax (medicine for graduate student series)
Anthrax  (medicine for graduate student series)Anthrax  (medicine for graduate student series)
Anthrax (medicine for graduate student series)
 
typhoid.pptx
typhoid.pptxtyphoid.pptx
typhoid.pptx
 
MALARIA.ppt
MALARIA.pptMALARIA.ppt
MALARIA.ppt
 
Arthopod vector borne diseases
Arthopod vector borne diseases Arthopod vector borne diseases
Arthopod vector borne diseases
 
CHEMO-IMMUNOTHERAPY FOR GLANDERS
CHEMO-IMMUNOTHERAPY FOR GLANDERSCHEMO-IMMUNOTHERAPY FOR GLANDERS
CHEMO-IMMUNOTHERAPY FOR GLANDERS
 
Malaria
MalariaMalaria
Malaria
 
Malaria
MalariaMalaria
Malaria
 
Malaria
MalariaMalaria
Malaria
 
Malaria
Malaria Malaria
Malaria
 
Malaria introduction and epidemiology.ppt
Malaria introduction and epidemiology.pptMalaria introduction and epidemiology.ppt
Malaria introduction and epidemiology.ppt
 
Vector borne diseases
Vector borne diseasesVector borne diseases
Vector borne diseases
 
Ebola final
Ebola finalEbola final
Ebola final
 

Mehr von RAHUL PAL

Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
RAHUL PAL
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
RAHUL PAL
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
RAHUL PAL
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
RAHUL PAL
 

Mehr von RAHUL PAL (20)

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
 

Kürzlich hochgeladen

Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Kürzlich hochgeladen (20)

Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 

Malaria Presentation Onwards Rahul Pals.pptx

  • 1. MALARIA • Submitted to- Mr. Appras willas Submitted by: Rahul Pal
  • 2. INTRODUCTION • Malaria is a mosquito born-disease caused by plasmodium, which is transmitted by the bite of infected female anopheles mosquito. • The term malaria originated from Italian word: mal’ aria – “bad air”. - Malaria remains the world’s most devastating human parasitic infection. Malaria affects over 40% of the world’s population. WHO, estimates that there are 350-500 million cases of malaria worldwide. - In India 2 million cases & 100 deaths annually.
  • 3. HISTORY • Malaria is the associated disease have been noted 4000 years ago. • Malaria may have contributed to the decline of the Roman Empire, and was so pervasive in Rome that it was known as the “Roman fever”. • Scientific studies on malaria made their first significant advance in 1880, when Charles Louis Alphonse Laveran – a French army doctor working In the military hospital of Constantine in Algeria – observed parasites inside the red blood cells of infected people for the first time. For this & later discoveries, he was awarded the 1907 Noble prize for physiology or medicines. • The first effective treatment for malaria came from the bark of cinchona tree, which contains quinine.
  • 4. SYMPTOMS OF MALARIA • Physical findings may include: • Elevated temperature. • Weakness. • Enlarged spleen. • Increased respiration rate.
  • 5. OTHER SYMPTOMS: • Dry cough. • Muscle or back pain or both. • Loss of consciousness. • Infection of brain or spinal cord. • Skin may be chills & sweating. • Nausea & vomiting.
  • 6. PATHOGENESIS • Incubation period:10-14 days in P.vivax, P.falciparum & P. oval but it 28-30 days in P.malariae. • The typical clinical features consists of febrile paroxysm, anemias & splenomegaly.
  • 7. STAGES OF DISEASE • Cold stage= -feeling of intense cold. • -Vigorous shivering, rigor. • - Lasts 15-60 min. • Hot stage- = Intense heat. • =Dry burning skin. • = Lasts 2-6 hours. • Sweating stage= -Profuce sweting. • - Declining temperature. • -Lasts 2-4 hours.
  • 8. DIAGNOSIS • Laboratory: thin, thick smears, antigen capture & PCR etc. • Clinical : platelets. • Other tastes: CBC • Lukopenia, throbocytobenia & increase ESR. • Chest x ray- helpful if respiratory symptoms are present. • CT scan- to evaluate evidence of cerebral edema or hemorrhage.
  • 9. TREATMENT Drug: • 01). Cloroquine. • 02). Primaquine. • 03). quinine. • 04). Artemisinin. Active Ingredient • 4-aminoquinolone. • 8-aminoquinolone. • Quinine. • Sesquiterpene lactone.